As Introduced
Underlined text would be added to current law. Struck-through text would be removed.
Skip to main content
Kansas Legislature
kslegislature.gov
menu
Home
House
account_balanceAbout the House
groupsRepresentatives
campaignEvents
chairSeating Chart
auto_storiesJournals & Calendars
manage_accountsChief Clerk of the House
gavelRules
Senate
account_balanceAbout the Senate
groupsSenators
campaignEvents
assignment_indAppointments
chairSeating Chart
auto_storiesJournals & Calendars
manage_accountsSecretary of the Senate
gavelRules
Committees
groupsCommittees
eventHearing Schedule
handshakeConference Committee Schedule
Measures & Laws
gavelAll Measures
account_balanceHouse Measures
account_balanceSenate Measures
account_balanceVotes
topicSubject Index
summarizeReports
menu_bookStatutes
schoolHow a Bill Becomes Law
menu_bookLegislative Procedure Manual
Today
campaignLive Floor Activity
videocamHouse Video
videocamSenate Video
live_tvStatehouse Live & Archive
smart_displayYouTube Channel
Resources
Archive
Search
description
Go to bill or resolution
arrow_forward
A−
A+
search
Search bills, resolutions, and statutes
help
or12(3) urinary tract infection; or13(4) COVID-19.14(b) The collaborative drug therapy management advisory committee 15established pursuant to K.S.A. 65-1677, and amendments thereto, may 16adopt a statewide protocol for each condition listed in subsection (a). In 17establishing such statewide protocols, the committee shall specify:18(1) The medications or categories of medications included in the 19protocol for each health condition;20(2) the training or qualifications required for pharmacists to 21implement the protocols;22(3) requirements for documentation and maintenance of records, 23including patient inclusion and exclusion criteria, medical referral criteria, 24patient assessment tools based on current clinical guidelines, follow-up 25monitoring or care plans and the pharmacist's adherence to the applicable 26protocols; and27(4) communication requirements, including, but not limited to, 28notification to the patient's personal or primary care provider.29(c) The board may deny an application or renewal or revoke or 30suspend the license of a pharmacist upon a finding that the pharmacist has 31violated the provisions of this section or failed to practice within the 32framework of statewide protocols established pursuant to this section by 33the collaborative drug therapy management advisory committee.34(d) This section shall take effect and be in force on and after July 1, 12022.2Sec. 2. K.S.A. 2024 Supp. 65-16,131 is hereby repealed.3Sec. 3. This act shall take effect and be in force from and after its 4publication in the statute book.
search
keyboard_arrow_up
keyboard_arrow_down
Page 1
Page 2
arrow_upward
Top
Kansas State Legislature
In-State: 1-800-432-3924
Out-of-State: 785-296-2149
Keywords
Enter any words to search bills, statutes, and documents.
water quality funding
Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611
Statute Number
68-102 72-3715
Exact Phrase
Wrap your query in quotes.
“rules of evidence”
Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget
Searching…
No results found.
search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search- HB 2157›
- HB 2157 — As Introduced
Kansas Legislature
HB 2157 — As Introduced
picture_as_pdf Download PDF Session of 2025HOUSE BILL No. 2157By Committee on Health and Human ServicesRequested by Heather Sprague on behalf of the Kansas Association of Chain Drugstores1-291AN ACT concerning pharmacists and pharmacy; relating to the state board 2of pharmacy; expanding the pharmacist's scope of practice to include 3point-of-care testing for and treatment of COVID-19; amending K.S.A. 42024 Supp. 65-16,131 and repealing the existing section.56Be it enacted by the Legislature of the State of Kansas:7Section 1. K.S.A. 2024 Supp. 65-16,131 is hereby amended to read as 8follows: 65-16,131. (a) A pharmacist may initiate therapy within the 9framework of a statewide protocol for the following health conditions:10(1) Influenza;11(2) streptococcal pharyngitis;300 SW 10th Ave, Topeka, KS 66612
Ad Astra Per Aspera
Kansas Legislative HotlineIn-State: 1-800-432-3924
Out-of-State: 785-296-2149
Government
- Legislators
- House
- Representatives
- Senate
- Senators
- Committees
Resources
- Bills & Measures
- Today
- Live
- Journals
- Calendars
- Archived Records
- Laws
- Search
- RSS Feeds
Support
- Contact Us
- Accessibility
- Privacy Policy
- Visit Us
Official text from the Kansas Legislature. Formatting has been adapted for reading on Ratifi.